DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Antibiotics are 26




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_0371Cephapirin Sodium
Antibiotics
Bacterial infections
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26041706
DrugRepV_0918Cephalexin Monohydrate
Antibiotics
Bacterial infections
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (54.225 %)
Approved
27476412
DrugRepV_1250Cefoxitin Sodium
Antibiotics
Bacterial infections
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (48.11 %)
Approved
27476412
DrugRepV_1312Cefazolin Sodium
Antibiotics
Bacterial infections
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (48.205 %)
Approved
27476412
DrugRepV_2642Cephalexin
Antibiotics
Bacterial infections
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-2.0410882 %)
Approved
27742486
DrugRepV_2869Enrofloxacin
Antibiotics
NA
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-7.5865927 %)
NA
27742486
DrugRepV_3088Nigericin Sodium
Antibiotics
NA
Chikungunya virus
CHIKV-0708
NA
Immunoflourescence assay
Decrease (100 %)
NA
23275491
DrugRepV_3276Bafilomycin
Antibiotics
Bacterial infection
Chikungunya virus
NA
NA
Flow cytometry
Decrease (50 %)
Experimental
27177310
DrugRepV_3295Bafilomycin
Antibiotics
Bacterial infection
Influenza virus
NA
Pathway
Flow cytometry
Decrease (100 %)
Experimental
27177310
DrugRepV_3299Bafilomycin
Antibiotics
Bacterial infection
Chikungunya virus
NA
NA
Flow cytometry
Decrease (100 %)
Experimental
27177310
DrugRepV_4037Monensin
Antibiotics
Bacterial infections
Hendra virus
NA
NA
Immunolabeling assay
Decrease (50 %)
Experimental, Vet approved
20668647
DrugRepV_4052Monensin
Antibiotics
Bacterial infections
Nipah virus
NA
NA
Immunolabeling assay
Decrease (50 %)
Experimental, Vet approved
20668647
DrugRepV_4088Bafilomycin A1
Antibiotics
NA
Ebola virus
Mayinga
NA
Inhibition assay
Decrease (50 %)
Experimental
26069727
DrugRepV_4089Bafilomycin A1
Antibiotics
NA
Ebola virus
Bundibugyo
NA
Inhibition assay
Decrease (50 %)
Experimental
26069727
DrugRepV_4090Bafilomycin A1
Antibiotics
NA
Marburg virus
Lake Victoria isolate
NA
Inhibition assay
Decrease (50 %)
Experimental
26069727
DrugRepV_4091Bafilomycin A1
Antibiotics
NA
Influenza virus
A/turkey/ England/50-92/91
Pathway
Inhibition assay
Decrease (50 %)
Experimental
26069727
DrugRepV_5071Brefeldin A
Antibiotics
Bacterial infections
Zika virus
NA
NA
Virus titration assay
Decrease (50 %)
Experimental
29093640
DrugRepV_5221Monensin
Antibiotics
Bacterial infections
Rift Valley fever virus
RVF-VLPs
NA
RLuc expression
Decrease (97.9 %)
Experimental, Vet approved
21994655
DrugRepV_5537Bafilomycin A1
Antibiotics
NA
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Experimental
32353859
DrugRepV_5823Brefeldin A
Antibiotics
Bacterial infections
Dengue virus
NA
Pathway
Immunoflourescence assay
Decrease (47.12 %)
Experimental
22155902
DrugRepV_6146Brefeldin A
Antibiotics
Bacterial infections
Dengue virus
NA
Pathway
Virus titration assay
Decrease (50 %)
Experimental
29093640
DrugRepV_6147Brefeldin A
Antibiotics
Bacterial infections
Dengue virus
NA
Pathway
Virus titration assay
Decrease (50 %)
Experimental
29093640
DrugRepV_6148Brefeldin A
Antibiotics
Bacterial infections
Dengue virus
NA
Pathway
Virus titration assay
Decrease (50 %)
Experimental
29093640
DrugRepV_6149Brefeldin A
Antibiotics
Bacterial infections
Dengue virus
NA
Pathway
Virus titration assay
Decrease (50 %)
Experimental
29093640
DrugRepV_6336Brefeldin A
Antibiotics
Bacterial infections
Dengue virus
New Guinea C
Pathway
Immunoflourescence assay
Decrease (47.12 %)
Experimental
22155902
DrugRepV_7250Brefeldin A
Antibiotics
Bacterial infections
Japanese encephalitis virus
NA
Pathway
Virus titration assay
Decrease (50 %)
Experimental
29093640